Common CIRS Comorbidities and Coinfections

Common Chronic Inflammatory Response Syndrome (CIRS) comorbidities and coinfections can make an already complex illness feel even harder to understand. Many patients begin with mold exposure or a suspected biotoxin illness, only to discover that their symptoms overlap with various conditions or other hidden stressors.

 

This is one reason CIRS can be so confusing. Multi-system symptoms, inflammation, and immune dysregulation can all point in different directions, leaving many patients with incomplete answers or disconnected diagnoses.

 

In clinical practice, we usually see that CIRS doesn’t happen in isolation. Biotoxin illness can weaken resilience, burden detoxification pathways, disrupt immune signaling, and create a terrain where other infections, inflammatory conditions, and chronic stress patterns become more difficult to overcome. At the same time, these comorbidities and coinfections can intensify CIRS symptoms, stall progress, and make treatment feel unpredictable when they are not properly identified.

 

Let’s explore the most common CIRS comorbidities and coinfections we see in practice, how they may correlate with CIRS, and why root-cause investigation is essential for lasting healing. While every case is unique, understanding these connections can help patients move beyond symptom chasing and toward a more complete, individualized path forward.

 

Key Takeaways

• CIRS comorbidities and coinfections are common because biotoxin illness can affect multiple systems across the body.
• Chronic inflammation, immune dysregulation, poor detoxification, gut barrier dysfunction, and neuroinflammation may make CIRS patients more vulnerable to overlapping conditions.
• Common CIRS comorbidities may involve immune, neurological, autonomic, connective tissue, gut, hormonal, sleep, and pain-related patterns.
• CIRS coinfections and colonizations can add to the body’s total inflammatory burden and may complicate recovery.
• Mold, Lyme, MARCoNS, gut infections, viral reactivation, parasites, heavy metals, and dental infections may all need to be considered in complex CIRS cases.
• CIRS can mimic other chronic illnesses, making root-cause testing and clinical pattern recognition especially important.
• Treatment order matters because comorbidities and coinfections can affect detox capacity, treatment tolerance, and symptom flares.
• Some overlapping conditions may improve through CIRS treatment alone, while others require separate individualized support.
• Testing for CIRS comorbidities and coinfections must be interpreted in context because timing and test limitations can affect results.
• A personalized root-cause approach can help CIRS patients move beyond symptom management toward remission, resilience, and long-term healing.

 

 

What Is CIRS?

 

 

Chronic Inflammatory Response Syndrome, or CIRS, is a complex inflammatory illness that can develop when the body is unable to properly resolve exposure to certain biotoxins. Instead of clearing the exposure and returning to baseline, the immune system can remain stuck in a prolonged inflammatory state.

 

This ongoing immune activation can affect many areas of the body at once, which is why CIRS symptoms often seem scattered or unrelated. A person may experience brain fog, fatigue, pain, sleep disruption, mood changes, digestive issues, hormone shifts, temperature dysregulation, chemical sensitivity, or other symptoms that do not fit neatly into one diagnosis. For many patients, this multi-system pattern is one of the first clues that something deeper may be driving the illness.

 

CIRS can also be difficult to identify through standard medical testing alone. Routine labs don’t capture the immune, inflammatory, hormonal, genetic, and environmental patterns often involved in biotoxin illness. A more complete assessment typically includes a detailed symptom history, exposure timeline, environmental evaluation, visual contrast sensitivity screening, HLA-DR/DQ haplotype testing when appropriate, and specialized inflammatory markers such as C4a, TGF-beta 1, MMP-9, MSH, VIP, VEGF, ADH/osmolality, and other relevant labs.

 

Since CIRS can overlap with many other chronic conditions, patients are commonly told their labs look normal or are given partial diagnoses that do not explain the full picture. Understanding CIRS through a root-cause lens helps connect these patterns and identify the exposures, immune dysfunction, and downstream imbalances that may be keeping the body inflamed. This is what allows care to move beyond symptom management and toward a more targeted, individualized healing plan.

 

 

In those who are genetically or immunologically susceptible, CIRS typically begins when the immune system encounters biotoxins or other inflammatory exposures it can’t properly clear. These triggers can keep innate immune pathways activated, creating a cycle of inflammation that continues even after the original exposure is reduced or removed.

 

Some of the most common CIRS-related triggers include:

 

• Water-damaged buildings: Damp indoor spaces are one of the most common sources of CIRS-related exposure. These environments can contain mold fragments, mycotoxins, bacteria, actinomycetes, endotoxins, and other microbial byproducts that can become airborne and inhaled. Even when mold is no longer actively growing, leftover fragments and microbial debris may still contribute to immune activation in sensitive individuals.
• Tick-borne and vector-borne infections: Infections transmitted through ticks, mosquitoes, fleas, or other vectors may also contribute to biotoxin illness and chronic inflammation. Lyme disease, Babesia, Bartonella, Ehrlichia, and other vector-related infections can place ongoing pressure on the immune system, especially when they are missed, undertreated, or layered on top of mold-related illness.
• Biotoxins from seafood: Certain fish and shellfish can carry naturally occurring marine toxins, including ciguatoxins from reef fish exposed through the food chain. These toxins may trigger acute illness in some people and, in susceptible individuals, may contribute to longer-lasting inflammatory symptoms.
• Harmful algal blooms: Cyanobacteria and dinoflagellates can release toxins into freshwater, coastal water, and marine environments. Exposure may occur through contaminated drinking or recreational water, inhalation of aerosolized particles, or skin contact during swimming, boating, or other water activities.
• Other environmental and biological stressors: CIRS can also be influenced by additional exposures that burden immune regulation, such as chronic viral infections, endotoxins, actinomycetes, volatile organic compounds, chemical exposures, and certain medical or environmental stressors. While these may not always be the primary trigger, they can worsen the inflammatory load and make recovery more difficult when the body is already dysregulated.

 

These exposures don’t affect everyone in the same way. For some people, the body can clear the trigger and return to balance. For others, especially those with immune susceptibility, the exposure may set off a persistent inflammatory response that requires deeper investigation into both the environment and the body’s internal terrain.

 

 

Biotoxins are tiny, biologically active compounds that can interfere with normal immune communication. Because they are small and chemically complex, they may move through the body in ways that are difficult to detect with routine labs. While contaminated indoor air from water-damaged buildings is one of the most recognized exposure routes, biotoxins may also come from certain foods, contaminated water, harmful algal blooms, or infections carried by ticks and other vectors.

 

However, biotoxin exposure does not automatically mean someone will develop CIRS. Many people encounter these substances and recover without ongoing symptoms. The difference often comes down to immune susceptibility, genetic patterns, total inflammatory load, and the body’s ability to recognize, bind, and eliminate these compounds.

 

This is where cumulative stress becomes important. Major immune challenges such as infections, surgery, toxic chemical exposure, pregnancy, trauma, or prolonged emotional stress can reduce the body’s resilience and increase inflammatory signaling. For someone with susceptible HLA-DR/DQ patterns or an already burdened immune system, this added stress may be enough to shift the body from temporary inflammation into a more persistent CIRS pattern.

 

In those who are vulnerable, the immune system may fail to properly tag and clear biotoxins. Instead of resolving the exposure, inflammatory pathways remain activated, allowing symptoms to continue across multiple systems. This is why biotoxin illness may begin suddenly after a clear event, or develop slowly over time as exposures and stressors accumulate.

 

For a more detailed understanding of CIRS, click here.

 

Pro-Tip: If you think you’re suffering from CIRS, you can learn more about CIRS diagnostic testing here.

 

What Is the Shoemaker Protocol?

 

 

Developed by Dr. Ritchie Shoemaker, the Shoemaker Protocol is a step-by-step clinical framework used to evaluate and treat CIRS and other biotoxin-related illnesses. Rather than focusing only on symptom relief, the protocol is designed to identify the exposure, reduce the biotoxin burden, calm the inflammatory response, and help restore immune regulation over time.

 

A key principle of the Shoemaker Protocol is sequencing. In CIRS care, the order of treatment matters because certain therapies may be less effective, or even poorly tolerated, if the body is still being exposed to biotoxins or if inflammation remains too active. This is why the protocol begins with identifying and removing ongoing exposure. For many patients, this includes evaluating water-damaged buildings, endotoxins, and other environmental triggers that may be keeping the immune system stuck in a reactive state.

 

Once exposure is addressed, the next phase often focuses on binding and removing biotoxins. Prescription binders such as cholestyramine or Welchol may be used to reduce toxin recirculation through bile and the digestive tract. This step can help lower the inflammatory burden, but it must be approached carefully, especially in patients with constipation, gut inflammation, medication sensitivities, nutrient depletion, or mast cell reactivity.

 

From there, the protocol works through additional layers of immune and inflammatory correction. In later stages, Vasoactive Intestinal Peptide, or VIP, may be considered when the patient is no longer exposed, the biotoxin burden has been reduced, and key lab markers suggest the body is ready. VIP is not meant to be used as a shortcut. When introduced too early, before foundational issues are corrected, it may not provide the intended benefit and can be harder for sensitive patients to tolerate.

 

While the Shoemaker Protocol provides an important roadmap, CIRS treatment should never be treated as a blanket recommendation checklist. Many patients also have comorbidities and coinfections. These overlapping conditions can influence which step comes first, how quickly treatment moves, what therapies are tolerated, and when more advanced interventions are appropriate.

 

For this reason, treatment should be personalized around the individual’s full clinical picture. 

 

CIRS Comorbidities and Coinfections Are So Common

 

 

CIRS comorbidities and coinfections are common because biotoxin illness can create a vulnerable internal terrain. When the immune system is stuck in a chronic inflammatory response, the body has fewer resources available for repair, detox, infection defense, nervous system regulation, gut integrity, hormone balance, and cellular energy production. Over time, this can make other conditions more likely to appear, worsen, or become harder to resolve.

 

This doesn’t mean CIRS is always the only root cause. 

 

Many patients have multiple contributing factors, including genetics, infections, trauma, toxic exposures, nutrient deficiencies, gut dysfunction, environmental stressors, and long-standing immune dysregulation. However, CIRS can be a major driver that keeps the body reactive and inflamed, especially when ongoing exposure is still present.

 

One reason this happens is that CIRS can disrupt normal immune signaling. Instead of mounting an appropriate response and then returning to baseline, the immune system remains activated. This ongoing inflammatory state can make the body more reactive. 

 

Poor detox can also play a role. In CIRS, the body struggles to properly identify, bind, and eliminate biotoxins, allowing inflammatory compounds to continue circulating. When toxin clearance is impaired, the liver, bile flow, gut, lymphatic system, kidneys, and drainage pathways can become more burdened. This usually increases sensitivity and tolerance levels.

 

Low MSH is another important piece of the CIRS picture. Melanocyte-stimulating hormone helps regulate immune balance, inflammation, gut barrier function, mucosal defenses, pain signaling, sleep, and hormone communication. When MSH is low, the gut lining and mucosal barriers can become more vulnerable, making it easier for certain infections to develop or persist. This can create a cycle where gut inflammation adds more immune stress to an already inflamed system.

 

Neuroinflammation can further complicate this picture. Many CIRS patients experience brain fog, mood changes, sleep disruption, sensory sensitivity, headaches, anxiety, depression, and nervous system hypervigilance. When the brain and nervous system are inflamed, the body may stay in a heightened threat state, making it harder to regulate immune responses and recover from everyday stressors.

 

This is why CIRS typically overlaps with so many other diagnoses. 

 

Comorbidity vs. Coinfection

 

 

A comorbidity is an additional health condition that exists alongside CIRS. It may share similar symptoms, develop as the body becomes more inflamed and dysregulated, or worsen when CIRS is active.

 

A coinfection is an infection, colonization, or microbial overgrowth that occurs alongside CIRS and adds to the body’s overall immune burden.

 

The main difference is that a comorbidity is an overlapping condition, while a coinfection involves an infectious or microbial driver. Both can complicate CIRS by increasing inflammation, worsening symptoms, lowering treatment tolerance, and making recovery less predictable.

 

In real-world cases, the line is not always perfectly clear. Some conditions involve both inflammatory and microbial components, which is why root-cause care looks beyond labels and asks what is actually keeping the body reactive, inflamed, and unable to heal.

 

Understanding Complex Chronic Illness for Root-Cause Healing

 

 

Root-cause healing requires looking at the full picture and not just the primary diagnosis. In CIRS, symptoms often come from a layered mix of biotoxin exposure, immune dysregulation, inflammation, infections, gut dysfunction, nervous system stress, and other overlapping conditions. When these layers aren’t identified, treatment can become frustrating, incomplete, or difficult to tolerate.

 

Understanding which comorbidities and coinfections are present helps clarify what the body needs first. One person may need to prioritize environmental cleanup and binders, while another may need mast cell stabilization and gut support before deeper CIRS treatment can be tolerated.

 

This is why individualized care is essential. 

 

Common CIRS Comorbidities

 

 

In clinical practice and throughout the CIRS community, certain comorbidities appear more frequently in patients dealing with biotoxin illness. These overlapping conditions aren’t always caused by CIRS alone, but they can be influenced, intensified, or prolonged by the chronic inflammatory patterns that CIRS creates.

 

Mast Cell Activation Syndrome (MCAS) and Histamine Intolerance

 

 

Mast cell activation syndrome (MCAS) and histamine intolerance are two common overlapping conditions we see in patients with CIRS, but they are not the same. MCAS involves inappropriate or excessive mast cell activation, where mast cells release histamine and other inflammatory mediators in response to foods, chemicals, stress, temperature changes, infections, or environmental exposures. 

 

Histamine intolerance is more specifically related to difficulty breaking down or regulating histamine, typically leading to symptoms after higher-histamine foods or when the body’s histamine burden becomes too high.

 

Patients with CIRS may have MCAS, histamine intolerance, or both. Mold, biotoxins, and other environmental exposures that drive CIRS can also be major root-cause triggers for mast cell reactivity. When the immune system is already on high alert from chronic biotoxin exposure, mast cells become more vigilant and reactive, lowering the threshold for food reactions, chemical sensitivity, and other multi-system symptoms that often overlap with CIRS.

 

Since the symptoms can look so similar, tracking patterns becomes essential. Stabilizing mast cells, improving histamine regulation, and supporting nervous system safety are foundational, important first steps before deeper CIRS treatment begins, because a highly reactive system may not tolerate binders, detox therapies, environmental changes, or antimicrobial protocols without careful preparation.

 

You can learn more in-depth about how MCAS and histamine intolerance manifest and how best to support them here. 

 

POTS and Dysautonomia

 

 

Postural orthostatic tachycardia syndrome (POTS) is a form of dysautonomia, which means the autonomic nervous system is not properly regulating automatic functions such as heart rate, blood pressure, digestion, temperature control, sweating, and circulation. In POTS, symptoms typically worsen when moving from lying down to sitting or standing, often because the body struggles to regulate blood flow and heart rate efficiently.

 

In CIRS patients, POTS and dysautonomia can overlap with chronic inflammation, MCAS, histamine reactivity, connective tissue patterns, low blood volume, electrolyte imbalance, mitochondrial stress, and nervous system dysregulation. These conditions can feed into one another, creating a cycle where inflammation increases autonomic instability, and autonomic instability makes the body less resilient to detox, treatment, stress, and environmental exposures.

 

Common symptoms in CIRS patients with POTS may include:

 

• Lightheadedness or dizziness when standing
• Rapid heart rate or palpitations
• Exercise intolerance or post-exertional crashes
• Fatigue, weakness, or shakiness
• Brain fog or difficulty concentrating
• Temperature dysregulation
• Nausea, reflux, constipation, or other motility issues
• Shortness of breath or air hunger

 

Autonomic stability is an important foundation for CIRS recovery because the body needs enough regulation to tolerate the treatment protocol. Support may include individualized hydration, minerals, compression, gentle movement, mast cell stabilization, blood sugar support, vagal toning, and careful treatment sequencing based on the patient’s tolerance and root-cause drivers.

 

Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders

 

 

Ehlers-Danlos syndrome (EDS) refers to a group of connective tissue disorders that can affect collagen structure and tissue integrity, while hypermobility spectrum disorders describe symptomatic joint hypermobility that doesn’t always meet full EDS criteria. 

 

In complex chronic illness cases, especially hypermobile EDS (hEDS), we usually see overlap with joint instability, chronic pain, easy injury, poor proprioception, gut motility issues, dysautonomia, and higher sensitivity to physical and environmental stressors.

 

hEDS, POTS, and MCAS are commonly discussed together because connective tissue laxity can affect blood vessel tone, circulation, and autonomic regulation, while mast cell reactivity can increase inflammation, pain, flushing, and treatment intolerance. When CIRS is also present, this combination can make the body more reactive and less resilient, especially if biotoxin exposure or other ongoing triggers are adding more stress to an already sensitive system.

 

EDS can complicate CIRS treatment because patients may have a narrower tolerance window for certain parts of treatment. Supportive care may include gentle strength training, joint stabilization, mineral and electrolyte support, nervous system regulation, mast cell stabilization, gut motility support, careful physical therapy, and avoiding overly forceful manual therapies when instability is present. For these patients, CIRS care usually needs to move slowly and prioritize stabilization.

 

Autoimmunity

 

 

Autoimmunity is another common pattern seen in patients with CIRS, and in some cases, CIRS can be a major root-cause contributor through the biotoxin pathway. When biotoxins keep the innate immune system chronically activated, the body remains in a heightened inflammatory state that disrupts immune tolerance, increases oxidative stress, affects gut barrier integrity, and confuses normal immune signaling. 

 

Some CIRS practitioners estimate that a significant percentage of autoimmune patients may have underlying CIRS or biotoxin illness, with estimates as high as 80% in certain clinical populations, especially among complex chronic illness cases that don’t respond well to standard care.

 

CIRS can also mimic or overlap with autoimmune disease because both can involve fatigue, joint pain, muscle pain, neurological symptoms, rashes, digestive issues, hormone changes, brain fog, and systemic inflammation. 

 

In some patients, autoimmune labs may be positive, indicating a clear diagnosis. In others, symptoms may look autoimmune, but conventional markers are normal or inconsistent because the underlying driver is chronic immune activation from biotoxin exposure rather than classic autoimmunity.

 

Common autoimmune conditions and autoimmune patterns seen in CIRS patients include:

 

• Hashimoto’s thyroiditis
• Graves’ disease
• Rheumatoid arthritis
• Lupus or lupus-like symptoms
• Sjögren’s syndrome
• Celiac disease
• Psoriasis or psoriatic arthritis
• Inflammatory bowel disease or autoimmune gastritis
• Multiple sclerosis-like neurological patterns
• Autoimmune-related skin, joint, or connective tissue symptoms

 

For root-cause healing, immune triggers must be identified and addressed instead of only suppressing downstream inflammation.

 

PANS and PANDAS

 

 

Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) are immune-related conditions where a child develops sudden or dramatic neuropsychiatric symptoms. PANDAS is specifically associated with strep infections, while PANS may involve a broader range of immune triggers, including infections, environmental exposures, metabolic stress, or other inflammatory drivers.

 

In CIRS-susceptible children, these patterns can appear as abrupt changes in mood, behavior, cognition, sleep, appetite, sensory tolerance, or emotional regulation. Parents may notice sudden anxiety, OCD-like behaviors, tics, separation anxiety, rage episodes, regression, restrictive eating, urinary frequency, handwriting changes, school decline, insomnia, or intense sensory sensitivity. Because many of these symptoms can also overlap with other conditions and stressors, the full clinical picture matters.

 

Environmental exposures and biotoxins can add significant immune stress in vulnerable children. Pediatric CIRS care requires a highly individualized and nuanced approach from knowledgeable functional CIRS practitioners.

 

Ulcerative Colitis, Irritable Bowel Syndrome (IBS), and Irritable Bowel Disease (IBD)

 

 

Ulcerative colitis can be an important clinical sign of CIRS, and it is something we have seen in patients within our practice. While not every case of ulcerative colitis may be driven by CIRS, inflammatory bowel patterns can be a clue that the multiple systems are under significant stress. In the broader CIRS community, gut conditions such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are also commonly discussed because the biotoxin pathway can affect the gut in multiple ways.

 

One major factor is low MSH, which can weaken gut barrier function, mucosal immunity, and microbial balance. When the gut lining is more vulnerable, patients may be more prone to food reactions, dysbiosis, bacterial or fungal overgrowth, motility changes, bloating, constipation, diarrhea, abdominal pain, and inflammatory flares. 

 

Biotoxin illness can also burden bile flow and toxin elimination, since toxins are stored, recirculated, and cleared through the liver, bile, and digestive tract. When bile flow, motility, or gut integrity are impaired, detox and binder tolerance can become much more difficult.

 

This matters because gut inflammation can interfere with key parts of the Shoemaker Protocol. In our private practice, Empower Functional Health (EFH), we have commonly seen patients and clients better tolerate CIRS treatment after completing a personalized gut healing protocol first. 

 

Chronic Mental Illness and Neuropsychiatric Conditions

 

 

Chronic mental illness and neuropsychiatric conditions can be another clinical sign of CIRS that we have seen in our practice. While mental health is always multifactorial, mold exposure and other biotoxins can contribute to a physiological burden that affects the brain, immune system, and nervous system. For some patients, anxiety, depression, panic, OCD-like symptoms, irritability, emotional volatility, depersonalization, brain fog, poor stress tolerance, and sleep disruption can have deeper inflammatory and immune drivers that aren’t addressed by mental health support and diet alone.

 

Neuroinflammation, mast cell activation, inflammatory cytokines, limbic system sensitization, and toxin-related brain symptoms can all contribute to changes in mood, cognition, and emotional regulation. 

 

When the body is stuck in a chronic threat response, the brain can become more reactive. This can make symptoms feel unpredictable or difficult to control, especially when the underlying exposure or inflammatory trigger has not been identified.

 

Root-cause mental health support in CIRS must include both the biological and nervous system sides of healing. 

 

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

 

 

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and CIRS can look very similar because both can involve severe fatigue, post-exertional malaise, unrefreshing sleep, brain fog, pain, dizziness, sensory sensitivity, immune dysfunction, and reduced ability to function. 

 

Because these symptoms are broad and usually difficult to capture on routine labs, patients can be misdiagnosed, dismissed, or given a ME/CFS diagnosis without a deeper investigation into mold and biotoxin exposure.

 

In some cases, what appears to be ME/CFS may actually be CIRS, or CIRS may be one of the main contributors keeping the fatigue pattern active. Chronic biotoxin exposure can drive inflammation, neuroimmune dysfunction, mitochondrial stress, autonomic dysregulation, poor sleep, hormonal disruption, and impaired detox, all of which can create a body that feels depleted, inflamed, and unable to recover normally after exertion.

 

For patients with this presentation, pacing is essential. When energy is limited, pushing through fatigue too quickly can worsen crashes and lower treatment tolerance. 

 

Fibromyalgia and Chronic Pain Syndromes

 

 

CIRS can contribute to widespread pain through various pathways. When the immune system remains stuck in a biotoxin-driven inflammatory response, pain signaling can become amplified, making muscles, joints, fascia, nerves, and even normal daily movement feel more painful or draining.

 

Fibromyalgia is better understood as a root-cause clue rather than a complete diagnosis. It describes a symptom pattern of widespread pain, tenderness, fatigue, sleep disruption, and cognitive symptoms, but it doesn’t always explain why the pain is happening. In many complex chronic illness cases, what has been labeled as fibromyalgia may actually be CIRS or may have CIRS as one of the major underlying drivers.

 

Pain support during CIRS treatment requires a holistic, individualized approach. An anti-inflammatory, nutrient-dense diet like Carnivore can help lower immune reactivity for some patients, while nervous system regulation and mast cell stabilization can all help reduce pain burden over time.

 

Multiple Chemical Sensitivity (MCS)

 

 

Multiple chemical sensitivity (MCS) is common in CIRS because the body can become more reactive to everyday exposure. Patients may notice stronger reactions to fragrances, cleaning products, smoke, pesticides, personal care products, new furniture, building materials, or volatile organic compounds (VOCs), which can make normal environments feel difficult or unsafe to tolerate.

 

Chemical exposures can add to the total CIRS load by increasing oxidative stress, irritating the respiratory system, triggering mast cells, burdening detox pathways, and worsening neurological symptoms. For some patients, CIRS can be one of the primary drivers of chemical intolerance because biotoxin illness can lower the threshold for reacting to additional environmental stressors.

 

Environmental simplification and detox support are typically foundational while healing. 

 

Traumatic Brain Injuries (TBIs), Migraines, and Neurological Conditions

 

 

Traumatic brain injuries (TBIs), migraines, and other neurological conditions can overlap with CIRS because biotoxin illness can directly affect the brain. A traumatic brain injury can also act as a major physiological stressor that triggers the onset of CIRS in susceptible individuals, especially when the immune system is already burdened. 

 

CIRS can contribute to migraines and neurological symptoms through neuroinflammation, mast cell activation, cytokine signaling, vascular changes, impaired oxygen delivery, autonomic dysfunction, and toxin-related effects on the brain. Patients commonly experience symptoms ranging from headaches to vertigo and word-finding difficulty. 

 

Some CIRS practitioners theorize that biotoxin illness is one of the overlooked root-cause contributors in neurological conditions such as Alzheimer’s disease, dementia, Parkinson’s disease, and other neuroinflammatory or neurodegenerative presentations. While these conditions are complex and multifactorial, patients with CIRS and neurological symptoms often need a careful, individualized approach that supports the brain.

 

Hormone Imbalances and Thyroid Dysfunction

 

 

CIRS can disrupt hormonal signaling by placing chronic stress on the hypothalamic-pituitary-adrenal (HPA) axis, immune system, sleep-wake cycle, and inflammatory pathways. When the body is stuck in a biotoxin-driven threat response, it can alter cortisol rhythm, thyroid conversion, sex hormone production, and overall metabolic function.

 

Common hormone patterns seen in CIRS include:

 

• Low testosterone
• Low DHEA
• Low libido
• Irregular menstrual cycles
• Worsening PMS or perimenopausal symptoms
• Thyroid symptoms despite “normal” basic labs
• Poor T4-to-T3 conversion
• Temperature intolerance
• Blood sugar instability
• Cortisol rhythm disruption
• Poor stress resilience
• Sleep disruption or waking during the night

 

Since hormones are downstream messengers, treatment usually requires more than replacing or boosting hormones alone. 

 

Sleep Disorders

 

 

Sleep disorders are common in CIRS because biotoxin illness can disrupt many of the systems that regulate rest, repair, and circadian rhythm. 

 

Low MSH also plays an important role because MSH helps regulate several downstream pathways connected to sleep, including melatonin signaling. When MSH is suppressed, patients can experience lower melatonin production, disrupted sleep architecture, frequent waking, vivid dreams, night sweats, temperature dysregulation, or a wired-but-tired feeling at night. 

 

In some cases, CIRS can be one of the primary drivers behind chronic insomnia, non-restorative sleep, or long-standing sleep disorders that haven’t responded well to standard support.

 

Sleep is essential during active CIRS treatment because the body repairs, detoxifies, regulates inflammation, balances hormones, consolidates memory, and restores nervous system resilience during deep rest. Finding the right personalized sleep support should always be a priority, both for CIRS recovery and for long-term wellness.

 

Mitochondrial Dysfunction and Exercise Intolerance

 

 

CIRS can affect cellular energy by increasing inflammation, poor oxygen delivery, and mitochondrial stress. Since mitochondria help produce the energy needed for every major system in the body, patients commonly experience deep fatigue, muscle weakness, post-exertional crashes, poor stamina, brain fog, shortness of breath, or a heavy, battery-drained feeling that doesn’t improve with rest alone.

 

Exercise intolerance is prevalent in CIRS because the body may be caught in a push-pull pattern: movement is important for circulation, lymph flow, mitochondrial signaling, mood, nervous system regulation, and neurogenesis, but too much exertion can trigger crashes, inflammation, pain, mast cell flares, or autonomic symptoms. This is why pushing through can backfire for CIRS patients.

 

During treatment, the goal is to find movement the body can tolerate consistently, even if that starts with gentle walking or stretching. Mitochondrial and energy support may also be helpful, but it should be individualized so the body can rebuild capacity without being overwhelmed.

 

Common CIRS Coinfections and Colonizations

 

 

In addition to overlapping comorbidities, many CIRS patients also deal with persistent infections, microbial overgrowth, or colonization patterns that add to the body’s inflammatory burden.

 

MARCoNS and Chronic Sinus Infections

 

 

MARCoNS stands for Multiple Antibiotic Resistant Coagulase Negative Staphylococci, a type of antibiotic-resistant staph colonization that can live in the nasal passages and form biofilms. It is commonly discussed in CIRS because MARCoNS is frequently found in biotoxin-illness patients, especially when MSH is low and mucosal immune defenses are weakened. 

 

After MARCoNS, Staphylococcus aureus colonization is another common nasal finding in CIRS patients. Staph aureus is a different species of staph bacteria that can colonize the nose or skin and can contribute to inflammation in some individuals, although not everyone with staph colonization is symptomatic or requires the same level of intervention.

 

MARCoNS matters in CIRS because it contributes to chronic sinus inflammation, immune activation, biofilm formation, low MSH patterns, and treatment resistance. In the Shoemaker Protocol, MARCoNS treatment is one of the key steps, and it must be cleared before starting VIP therapy, which is typically considered the final step of the protocol. This sequencing is important because persistent MARCoNS can keep inflammatory signaling active and reduce the likelihood of a stable response to later-stage therapies.

 

Timing for staph treatment should be individualized. Fungal colonization in the nasal passages can also occur, especially in mold-susceptible patients, and treatment should be personalized.

 

Lyme, Coinfections, and Vector-Borne Illnesses

 

 

Lyme disease is a tick-borne infection most commonly associated with Borrelia species, while Lyme coinfections and vector-borne illnesses include other organisms transmitted by ticks, mosquitoes, fleas, or similar vectors. 

 

These infections can act as primary drivers in CIRS. Not everyone with Lyme has CIRS, but in clinical practice, many individuals with Lyme also appear sensitive to mold, water-damaged buildings, and other biotoxin exposures.

 

CIRS and Lyme can overlap significantly with many similar symptoms. One important nuance we have seen in practice is that some patients with CIRS initially test negative for Lyme or coinfections, then later test positive after enough mold and biotoxin burden has been cleared. 

 

As the immune system reorganizes and becomes more capable of mounting an antibody response, previously hidden infections may become easier to detect. More sensitive testing may be needed, but both testing and treatment require careful interpretation from a practitioner who understands CIRS, Lyme, immune suppression, and chronic inflammatory illness.

 

Treatment sequencing also requires individualization. Treating Lyme aggressively without addressing mold exposure and CIRS can fail because the body may remain too inflamed, reactive, and toxic to tolerate antimicrobials. In other cases, treating mold without addressing persistent infections can also stall because Lyme and other vector-borne illnesses may continue driving immune activation. 

 

Small Intestinal Bacterial Overgrowth (SIBO), Small Intestinal Fungal Overgrowth (SIFO), and Other Gut Infections

 

 

SIBO, or small intestinal bacterial overgrowth, occurs when excess bacteria grow in the small intestine, while SIFO, or small intestinal fungal overgrowth, involves fungal organisms such as Candida becoming overgrown in the small intestine. Both can contribute to bloating, gas, constipation, diarrhea, reflux, food reactions, abdominal pain, histamine symptoms, and poor tolerance to supplements or binders.

 

SIBO and SIFO are common in CIRS because biotoxin illness can weaken the gut terrain through low MSH, poor gut barrier integrity, altered immune defenses, impaired motility, bile flow disruption, and microbiome imbalance. Mold exposure can also increase fungal burden or contribute to mold-related colonization in vulnerable patients, especially when the gut lining is inflamed and the immune system is already dysregulated. This can create a cycle where CIRS worsens gut dysfunction, and gut infections or overgrowths add more inflammation back into the CIRS picture.

 

Other gut infections and microbial patterns that can be relevant in CIRS include:

 

• H. pylori
• C. difficile
• Shiga toxin-producing E. coli
• Pathogenic E. coli strains
• Klebsiella overgrowth
• Citrobacter overgrowth
• Pseudomonas overgrowth
• Streptococcus overgrowth
• Enterococcus imbalance
• Candida or other fungal overgrowth
• General dysbiosis
• Low beneficial bacteria
• Biofilm-associated gut infections

 

Parasites

 

 

Parasites can be a common colonization pattern in CIRS, Lyme disease, and other complex chronic illness cases where the body’s total toxin and immune burden has exceeded its capacity to regulate and clear stressors effectively. 

 

When the internal terrain is weakened, parasites can also behave opportunistically. Like bacteria, fungi, and viruses, they can contribute to biofilm formation, inflammatory signaling, nutrient depletion, histamine reactions, digestive symptoms, and treatment resistance. In some patients, parasites may not be the only root cause, but they can be one more layer keeping the immune system activated and the gut terrain unstable.

 

Addressing parasites through parasite cleansing, herbal protocols, or prescription antiparasitics requires careful timing and individualized support in CIRS treatment. 

 

Heavy Metals

 

 

Heavy metals can be another important toxin burden to consider in CIRS and other complex chronic illness cases. Because CIRS can involve poor detox and nutrient depletion, the body can have a harder time safely processing and eliminating toxic metals. When heavy metals accumulate, they can add to the total toxic load and may add additional stress.

 

This doesn’t mean heavy metals are always the primary driver, but they can be one more layer that keeps the body inflamed and less resilient. 

 

Heavy metal testing, provocation testing, mineral repletion, binders, and chelation therapy are all nuanced and should be carefully timed within the broader CIRS protocol. Mobilizing metals when detox pathway and elimination are not ready may risk redistributing metals into other tissues. For this reason, heavy metal support should be guided by an experienced practitioner who can personalize timing, dosing, drainage support, and safety monitoring.

 

Chronic Viral Reactivation

 

 

Chronic viral reactivation occurs when viruses that were previously dormant in the body become active again, often during periods of immune stress. Many viruses can remain latent for years after the initial infection, but when the immune system is overburdened by CIRS and other comorbidities and coinfections, the body can struggle to keep these viruses suppressed.

 

Common viral reactivation patterns seen in complex chronic illness include:

 

• Epstein-Barr virus (EBV)
• Cytomegalovirus (CMV)
• Human herpesvirus 6 (HHV-6)
• Herpes simplex virus (HSV-1 or HSV-2)
• Varicella-zoster virus
• Parvovirus B19
• Enteroviruses

 

Root-cause healing requires reducing the layers that keep the immune system overwhelmed and providing potential individualized viral support. As the total toxic and inflammatory burden comes down, the immune system typically has more capacity to regulate viral activity and support deeper recovery.

 

Dental and Oral Infections

 

 

Dental and oral infections can be hidden immune stressors in CIRS, especially when periodontal disease, root canal concerns, biofilms, jaw inflammation, or cavitations are present. Cavitations are areas of poorly healed or inflamed jawbone, typically at old extraction sites, where low-grade infection, impaired blood flow, or necrotic tissue may persist. These areas can become difficult for the immune system to fully clear and may add to the body’s overall inflammatory burden.

 

Oral biofilms, infected gums, root canal/wisdom teeth extraction complications, and jawbone inflammation can all contribute to chronic immune activation, especially in patients already dealing with CIRS. MARCoNS may also colonize cavitations or other vulnerable tissue areas, creating another potential reservoir for inflammation and treatment resistance.

 

Dental infections aren’t usually the first priority in CIRS treatment, but they may need to be investigated when symptoms persist, labs stall, or a patient is not progressing as expected. Working with a knowledgeable biological dentist can help identify and address dental issues that may be contributing to CIRS symptoms or creating a roadblock in recovery.

 

Chronic Urinary Tract Infections (UTIs), Bladder Inflammation, and Interstitial Cystitis Patterns

 

 

Chronic urinary tract infections (UTIs), bladder inflammation, and interstitial cystitis patterns can overlap with both CIRS and MCAS because the bladder lining, immune system, mast cells, nervous system, and microbiome are closely connected. Patients may experience frequent urination, urinary urgency, burning, pelvic pain, pressure, food-related flares, or symptoms that worsen with stress or inflammatory triggers.

 

It is important to distinguish true recurrent infections from chronic inflammation or mast-cell-driven bladder irritation. Some patients may have confirmed bacterial infections that require appropriate treatment, while others may have UTI-like symptoms with negative cultures.

 

Addressing the root cause at the right time is essential. Antibiotic overuse and proper care are important considerations. 

 

Respiratory Infections and Lung Inflammation

 

 

Respiratory infections and lung inflammation can be common concerns in CIRS because mold and other contaminants from water-damaged buildings can irritate the airways and keep the immune system activated. Patients may experience chronic coughing, wheezing, chest tightness, shortness of breath, post-nasal drip, recurrent bronchitis, asthma-like symptoms, air hunger, or throat irritation.

 

In some cases, these symptoms may reflect inflammatory airway irritation, while in others, they may involve infection, mold colonization, or another lung condition that needs medical attention. Since respiratory symptoms can sometimes indicate serious issues, lung-related symptoms should be evaluated carefully and promptly.

 

For CIRS patients, respiratory support usually requires both immediate medical evaluation when needed and long-term root-cause work.

 

How Comorbidities and Coinfections Affect CIRS Treatment

 

 

CIRS treatment can become more complex when multiple comorbidities, coinfections, or colonization patterns are involved. These additional layers can influence a variety of factors. 

 

Treatment Order and Timing Considerations

Treatment order and timing can vary widely in CIRS. Many CIRS patients aren’t dealing with one isolated issue—they often have multiple overlapping drivers that influence which step should come first and how quickly care can progress.

 

This is where CIRS treatment becomes both clinical science and clinical art. A knowledgeable, holistic, functional practitioner can help interpret these nuances and create a truly individualized plan that supports healing without overwhelming the body.

 

Treatment Sensitivity and Complexity

Treatment sensitivity can increase when a patient has had CIRS for a long time, especially when multiple comorbidities, coinfections, colonizations, or toxin burdens are also present. The number of overlapping conditions, the severity of each one, the degree of immune dysregulation, and the patient’s current detox and nervous system capacity can all affect how well they tolerate binders, antimicrobials, supplements, detox therapies, environmental changes, or later-stage protocol steps.

 

The more complex the case becomes, the more support is typically needed. 

 

Potential False Starts and Treatment Plateaus

CIRS recovery can sometimes involve early improvement followed by new symptoms or a frustrating plateau. This may happen when one major inflammatory layer is removed, but another deeper driver remains unaddressed. As the immune system begins to reorganize, inflammation decreases, and the body is no longer overwhelmed by the first major trigger; it may become more capable of revealing other drivers that were previously hidden under the larger inflammatory load.

 

We commonly see this when someone starts a Carnivore diet and initially feels significantly better, only to later notice symptoms returning or shifting. Similarly, a patient may normalize CIRS markers after proper remediation and binding, feel well for a time, and then develop new symptoms that later testing reveals to be Lyme or another underlying driver. These moments can feel like setbacks, but they are opportunities to uncover the next root-cause layer and refine the treatment plan more precisely.

 

Testing for CIRS Comorbidities and Coinfections

 

 

Testing can be an important step in understanding the full picture of illness, especially when CIRS overlaps with multiple other conditions. The right labs can help identify hidden drivers, clarify treatment priorities, and reveal why someone may be reactive, inflamed, stuck, or unable to tolerate certain parts of treatment.

 

However, testing isn’t always straightforward. Timing matters because the immune system may be too overburdened, suppressed, or dysregulated to create clear antibodies for certain infections early in treatment. This is why some patients may test negative for Lyme, coinfections, viruses, or other immune-mediated markers until enough inflammation, mold burden, or biotoxin load has been reduced. Testing can also have limitations, including false negatives, incomplete sensitivity, and results that require clinical context. For example, parasite PCR testing commonly misses organisms if they aren’t present in the sample collected.

 

This is why working with a knowledgeable practitioner is essential. A holistic CIRS-literate provider can help determine the right testing sequence, interpret results in context, understand the limitations of each method, and use symptoms, exposure history, labs, response to treatment, and clinical pattern recognition to complete the picture. The goal isn’t to test for everything at once, but to gather the right data at the right time so treatment can be more targeted and effective.

 

Root-Cause Treatment Considerations

 

 

Some CIRS comorbidities and coinfections may improve or fully resolve as the underlying biotoxin pathway is addressed. Certain overlapping symptoms or conditions may naturally become less active because the primary driver has been corrected.

 

Other conditions may require their own targeted protocols, therapies, and supportive care alongside CIRS treatment. 

 

True healing means helping the patient reach remission, rebuild resilience, and become stable enough to live a life that is as close to symptom-free as possible.

 

FAQ on Common CIRS Comorbidities and Coinfections

Here are some of our most frequently asked questions about common CIRS comorbidities and coinfections:

Closing Thoughts on Addressing CIRS Comorbidities and Coinfections

CIRS can be a challenging and complex condition to navigate, especially when other comorbidities, coinfections, colonizations, and toxin burdens are also present. For many patients, these overlapping layers can make symptoms harder to understand, treatment more sensitive, and recovery less straightforward than simply following one protocol from start to finish.

 

While this information can feel overwhelming, it can also be deeply empowering. Every diagnosis, symptom pattern, lab result, and treatment response offers another clue about what the body needs to heal. When these pieces are viewed through a root-cause lens, they stop being separate problems to chase and become part of a larger map toward recovery.

 

Healing from CIRS is about identifying the drivers that are keeping the body inflamed, supporting the systems that need stability, and addressing each layer in the right order. With knowledgeable guidance, personalized care, and a deeper understanding of the body’s patterns, it’s possible to achieve long-term resilience and remission.

 

Work With Our Trusted CIRS Functional Medicine Practitioners

Our Empower Functional Health practice is honored to be trusted CIRS functional practitioners, supporting patients and clients from around the globe. We’re passionate about helping individuals achieve root-cause healing in order to live the life they are meant to, nearly symptom-free. We provide environmental illness thought leadership and evidence-based insights, paired with clinical pearls, to help you achieve your wellness goals. We welcome you to explore our free resources, and if you find that self-troubleshooting falls short, we’re here to guide you with personalized support and protocols. If you believe you’re suffering from CIRS, our CIRS Testing + Session is the best place to start.

 

 

DISCLAIMER: This content is for educational purposes only. While we are board-certified in holistic nutrition and are functional practitioners, we are not providing medical advice. Whenever you start a new diet or protocol, always consult with your trusted practitioner first.